Clinicopathologic and prognostic significance of human epidermal growth factor receptor in patients with gastric cancer: An updated meta-analysis

Abstract

// <![CDATA[ $('.header-date').hide();$('#titleAuthors').hide();$('#abstractHeader').hide(); // ]]> Zhiqiao Zhang1, 3, *, Hongfeng Tang2, Jixin Lin3, Yunzhao Hu1, 3, **, Guanying Luo1, 3, *, Zhaowen Luo3, Canchang Cheng1, 3, Peng Wang1, 3 1Department of Infectious Disease, The First People’s Hospital of Shunde, Shunde, Guangdong, China 2Department of Science and Education, The First People’s Hospital of Shunde, Shunde, Guangdong, China 3Department of Internal Medicine, The Chencun Hospital Affiliated to The First People’s Hospital of Shunde, Shunde, Guangdong, China *These authors contributed equally to this study and were co-first authors **This author as a joint corresponding author contributed equally to this study as Peng Wang Correspondence to: Peng Wang, email: sdgrxjbk@163.com Keywords: gastric cancer, human epidermal growth factor receptor, meta-analysis, prognostic significance Abbreviations: Gastric cancer GC; human epidermal growth factor receptor EGFR; odds ratio OR; hazard ratio HR; confidence interval CI Received: July 11, 2016 Accepted: January 06, 2017 Published: February 09, 2017